EMBLAVEO Trademark

Trademark Overview


On Monday, January 30, 2023, a trademark application was filed for EMBLAVEO with the United States Patent and Trademark Office. The USPTO has given the EMBLAVEO trademark a serial number of 97773211. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, June 3, 2024. This trademark is owned by Allergan Pharmaceuticals International Limited. The EMBLAVEO trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations to treat infections; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
emblaveo

General Information


Serial Number97773211
Word MarkEMBLAVEO
Filing DateMonday, January 30, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, June 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 10, 2023

Trademark Statements


Goods and Servicespharmaceutical preparations to treat infections; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 16, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAllergan Pharmaceuticals International Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDublin 17 D17E400
IE

Party NameAllergan Pharmaceuticals International Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin 17 D17E400
IE

Trademark Events


Event DateEvent Description
Thursday, February 2, 2023NEW APPLICATION ENTERED
Thursday, February 16, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 31, 2023ASSIGNED TO EXAMINER
Friday, September 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 10, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 5, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 3, 2024SOU TEAS EXTENSION RECEIVED
Monday, June 3, 2024SOU EXTENSION 1 FILED
Monday, June 3, 2024SOU EXTENSION 1 GRANTED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED